Health Care/Hospital
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading global Contract Research, Developm...
2026-01-26 15:00
2637
Get Exclusive Limited-Edition Gifts During Your Lunar New Year Trip: Wakamoto Launches "Thank You from Wakamoto" Campaign
TOKYO, Jan. 26, 2026 /PRNewswire/ -- Wakamoto Pharmaceutical Co., Ltd. (Tokyo,
Arata Igarashi), a company dedicated to supporting healthy and active
lifestyles, will launch a nationwide campaign in which customers who purchase
"Strong Wakamoto" will receive an original hand towel.
2026-01-26 13:00
2278
Natural Good Things Achieves Major Success with Taiwanese Artist Halo Mavis, Records 250,000 Live Commerce Sales
SEOUL, South Korea, Jan. 26, 2026 /PRNewswire/ -- Women's wellness inner-care brand Natural Good Things (NGT) is making significant strides in the global market through a strategic partnershipwith Taiwanese artist and mega influencer Halo Mavis. NGT announced that it achieved cumulative sales of...
2026-01-26 11:00
3036
AXA Completes Re-domiciliation to Hong Kong
HONG KONG, Jan. 26, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") is pleased to announce the successful completion of the re-domiciliation of AXA China Region Insurance Company (Bermuda) Limited ("the Company") from Bermuda to Hong Kong, under the re-domiciliation regime introduced by Hong...
2026-01-26 10:05
1564
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
-Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30 demonstrated placebo-adjusted weight loss of up to 7.7% in a recently completed 13-week U.S. Phase II study in participants with obesity or o verweight, withbetter gastrointestina...
2026-01-26 08:10
2888
Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard
TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and Drug Administration (FDA). The agency's Master ...
2026-01-26 08:00
2525
Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
* Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study inthe United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles. * ISM8969 is a novel oral therapeutic candi...
2026-01-23 21:30
8436
Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026
DUBAI, UAE, Jan. 23, 2026 /PRNewswire/ -- Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution atWHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58). Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," Ozelle will highlight how dia...
2026-01-23 18:00
3751
The American Chamber of Commerce in Singapore (AmChamSG) Supports Blossom Seeds with Outreach to 400 Senior Households in Sembawang
Nearly 100 AmChamSG Members and Staff Commemorate Martin Luther King, Jr. Day of Service (MLK Day) by Supporting Senior Heartlanders in Need SINGAPORE, Jan. 23, 2026 /PRNewswire/ -- The American Chamber of Commerce in Singapore (AmChamSG) commemorated Martin Luther King, Jr. Day of Service (MLK ...
2026-01-23 17:15
5170
Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
AUCKLAND, New Zealand, Jan. 21, 2026 /PRNewswire/ -- Aroa Biosurgery Limited is pleased to announce that the latest publication from its ongoing prospective study, theMyriad Augmented Soft Tissue Reconstruction Registry (MASTRR), has been published in theJournal of Trauma and Injury. MASTRR is t...
2026-01-23 03:13
2838
Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
* New "AI GYM for Science" dramatically boosts the biological and chemical intelligence of any causal or frontier LLM * Up to 10x performance gains on key drug discovery benchmarks compared to LLMs that miss the mark on ~75–95% of tasks * Advances Insilico's vision of Pharmaceutical Superint...
2026-01-22 22:37
4518
Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation
SHENZHEN, China, Jan. 22, 2026 /PRNewswire/ -- May Li, Board Secretary of Mindray Medical (300760.SZ), delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference (JPM Conference) on January 15, 2026, outlining the company's strategic vision for the next decade centered on three core...
2026-01-22 22:11
6947
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
SHANGHAI, Jan. 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed ina clinical trial in the U.S. of its independently developed novel CDH17-targeting antibody-drug co...
2026-01-22 22:00
5008
Jin Medical Announces the Official Commencement Date of Chuzhou Facility
CHANGZHOU, China, Jan. 22, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment inChina, announced today that its wholly-owned subsidiary, Zho...
2026-01-22 21:57
6175
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
* CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccine * Collaboration addresses manufacturing complexity and cold-chain challenges to improve yield and thermostability * Partnership aims to expand affordable and sustainable vaccine access in low- an...
2026-01-22 21:00
4470
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
BURLINGTON, Mass., Jan. 22, 2026 /PRNewswire/ -- PAQ Therapeutics, a clinical-stage oncology company developing novel targeted protein degradation therapies for KRAS-driven cancers, today announced the closing of a Series B extension, bringing the company's total Series B financing to$77 million,...
2026-01-22 20:00
3198
pixelRo to Showcase AI-Powered Digital Healthcare and Air Sterilization Solutions at CES 2026 and WHX Dubai
SEOUL, South Korea, Jan. 22. 2026 /PRNewswire/ -- pixelRo, a Samsung Electronics spin-off digital healthcare company, is accelerating its global expansion by participating in CES 2026 and WHX Dubai 2026 (formerly Arab Health). pixelRo develops and operates AI-based integrated self-diagnostic kio...
2026-01-22 16:59
3550
BTL Announces Successful Enforcement of Patent Rights Relating to EMFACE® Against WonderFace Device
PRAGUE, Jan. 22, 2026 /PRNewswire/ -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. ("Lexter"), the manufacturer of the WonderFace device. The settl...
2026-01-22 16:00
2367
2026 Japan Prize Laureates Announced
TOKYO, Jan. 22, 2026 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2026 Japan Prize on January 21, 2026. Prof. Cynthia Dwork (USA) has received the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "Jame...
2026-01-22 14:00
1023
Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
* Positioning Telangana among the world's top five life sciences clusters by 2030 * Targets USD 25 billion in investments * Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ -- The Government of Telangana, India tod...
2026-01-22 09:00
3459
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 317 media titles]
2026-01-23 11:03
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 308 media titles]
2026-01-27 13:00
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 306 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 299 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
